Short-cycle therapy (5 days on/2 days off) with a lamivudine + dolutegravir regimen in a cohort of virologically suppressed patients with HIV infection

MeSH terms

• Adult
• Aged
• Anti-HIV Agents / adverse effects
• Anti-HIV Agents / therapeutic use*
• Antiretroviral Therapy, Highly Active / adverse effects
• Antiretroviral Therapy, Highly Active / methods*
• Cohort Studies
• Drug Therapy, Combination
• Female
• HIV Infections / drug therapy*
• Heterocyclic Compounds, 3-Ring / adverse effects
• Heterocyclic Compounds, 3-Ring / therapeutic use*
• Humans
• Lamivudine / adverse effects
• Lamivudine / therapeutic use*
• Male
• Middle Aged
• Oxazines / adverse effects
• Oxazines / therapeutic use*
• Piperazines / adverse effects
• Piperazines / therapeutic use*
• Pyridones / adverse effects
• Pyridones / therapeutic use*
• Reverse Transcriptase Inhibitors / adverse effects
• Reverse Transcriptase Inhibitors / therapeutic use*